These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10024471)

  • 1. Large-scale propagation of recombinant adherent cells that secrete a stable form of human glandular kallikrein, hK2.
    Kumar A; Goel AS; Payne JK; Evans C; Mikolajczyk SD; Kuus-Reichel K; Saedi MS
    Protein Expr Purif; 1999 Feb; 15(1):62-8. PubMed ID: 10024471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of human glandular kallikrein, hK2, in mammalian cells.
    Kumar A; Goel AS; Hill TM; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Saedi MS
    Cancer Res; 1996 Dec; 56(23):5397-402. PubMed ID: 8968092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2.
    Kumar A; Mikolajczyk SD; Goel AS; Millar LS; Saedi MS
    Cancer Res; 1997 Aug; 57(15):3111-4. PubMed ID: 9242434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and processing of prostate specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCaP cells.
    Väisänen V; Lövgren J; Hellman J; Piironen T; Lilja H; Pettersson K
    Prostate Cancer Prostatic Dis; 1999 Mar; 2(2):91-97. PubMed ID: 12496845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D.
    Hsieh ML; Charlesworth MC; Goodmanson M; Zhang S; Seay T; Klee GG; Tindall DJ; Young CY
    Cancer Res; 1997 Jul; 57(13):2651-6. PubMed ID: 9205072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
    Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
    J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of human glandular kallikrein, hK2, as its precursor form and in complex with protease inhibitors in prostate carcinoma serum.
    Grauer LS; Finlay JA; Mikolajczyk SD; Pusateri KD; Wolfert RL
    J Androl; 1998; 19(4):407-11. PubMed ID: 9733142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy.
    Yu DC; Sakamoto GT; Henderson DR
    Cancer Res; 1999 Apr; 59(7):1498-504. PubMed ID: 10197620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human glandular kallikrein hK2 from LNCaP cells.
    Grauer LS; Charlesworth MC; Saedi MS; Finlay JA; Liu RS; Kuus-Reichel K; Young CY; Tindall DJ
    J Androl; 1996; 17(4):353-9. PubMed ID: 8889697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer.
    Young CY; Seay T; Hogen K; Charlesworth MC; Roche PC; Klee GG; Tindall DJ
    Prostate Suppl; 1996; 7():17-24. PubMed ID: 8950360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
    Veveris-Lowe TL; Lawrence MG; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
    Endocr Relat Cancer; 2005 Sep; 12(3):631-43. PubMed ID: 16172196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions.
    Black MH; Magklara A; Obiezu C; Levesque MA; Sutherland DJ; Tindall DJ; Young CY; Sauter ER; Diamandis EP
    Br J Cancer; 2000 Jan; 82(2):361-7. PubMed ID: 10646889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
    Fisher TL; Nocera M; Willis RA; Turner MJ; Abdul Alim CS; Brown DM; Bourne PA; di Sant'Agnese PA; Messing EM; Lord EM; Frelinger JG
    Prostate; 2002 May; 51(3):153-65. PubMed ID: 11967950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue.
    Mikolajczyk SD; Millar LS; Marker KM; Rittenhouse HG; Wolfert RL; Marks LS; Charlesworth MC; Tindall DJ
    Cancer Res; 1999 Aug; 59(16):3927-30. PubMed ID: 10463585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling.
    Bridon DP; Dowell BL
    Urology; 1995 May; 45(5):801-6. PubMed ID: 7538242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
    Charlesworth MC; Young CY; Miller VM; Tindall DJ
    J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ala217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2.
    Mikolajczyk SD; Millar LS; Marker KM; Grauer LS; Goel A; Cass MM; Kumar A; Saedi MS
    Eur J Biochem; 1997 Jun; 246(2):440-6. PubMed ID: 9208936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained high-yield production of recombinant proteins in transiently transfected COS-7 cells grown on trimethylamine-coated (hillex) microcarrier beads.
    Knibbs RN; Dame M; Allen MR; Ding Y; Hillegas WJ; Varani J; Stoolman LM
    Biotechnol Prog; 2003; 19(1):9-13. PubMed ID: 12573000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
    Becker C; Piironen T; Pettersson K; Björk T; Wojno KJ; Oesterling JE; Lilja H
    J Urol; 2000 Jan; 163(1):311-6. PubMed ID: 10604382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
    Mize GJ; Wang W; Takayama TK
    Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.